ArticleJournal of human hypertension2025
Prevalence and determinants of masked hypertension among patients with type 2 diabetes mellitus.
Article in Journal of human hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blood Pressure Phenotypes in Patients Recently Diagnosed With Type 2 Diabetes Mellitus and Matched Controls: A Study in Urban Mozambique.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There had been no previous study that evaluated the prevalence of masked hypertension (MH), its determinants, and ambulatory blood pressure patterns among patients with type 2 diabetes mellitus (DM) in Nigeria. Among 222 individuals living with type 2 DM with normal clinic blood pressure (SBP < 140 mm Hg and DBP < 90 mm Hg), we obtained 24 h ambulatory blood pressure measurements. Patients were either untreated (77) or treated (145) with antihypertensive medications. The prevalence of MH among the normotensive (untreated) and hypertensive subgroups (treated) was 32.5 and 60% respectively. The prevalence of nocturnal hypertension among all patients was 71.6%, and was significantly higher among patients with masked phenomenon (98.2 vs 46.2%, p < 0.0001) compared to true normotension. The determinants of MH were 5 years or more duration of type 2 DM (odds ratio 2.71, 95% CI 1.21-6.27) and increasing clinic SBP (odds ratio 2.19, 95% CI 1.51-3.36). Masked hypertension is common among patients with type 2 DM. Higher clinic SBP and 5 years or more duration of type 2 DM are the risk factors.
Indexed as
Identifiers
41125771What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.